VPS34 suppression reverses osimertinib resistance via simultaneously inhibiting glycolysis and autophagy. Chen H, Lu C, Lin C, Li L, et al. Carcinogenesis 2021;42:880-890.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen H, Lu C, Lin C, Li L, et al. VPS34 suppression reverses osimertinib resistance via simultaneously inhibiting glycolysis and autophagy. Carcinogenesis 2021;42:880-890.
PMID: 33848354